Switch View
© BusinessWire
13.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter 2025 financial results and highlighted recent corporate updates.
“We significantly advanced our NGN-401 gene therapy clinical program for Rett synd...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
News Preview
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC).
If you currently own shares of iRhythm stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=22399 for more information...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
December 29, 2025 Deadline Approaching: Join Class Action Against Avantor, Inc. (AVTR) - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=177271&wire=5&utm_campaign...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Deadline Soon: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 17, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, i...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
13.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Investors in Tvardi Therapeutics, Inc. (TVRD) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ: TVRD) concerning possible violations of federal securities laws.On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZIMMER BIOMET HOLDINGS, INC. (ZBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintif...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
News Preview
Today, it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you purchase...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Reports Third Quarter 2025 Financial Results
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet’s Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results a...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S
News Preview
13 November 2025...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
13.11.2025
ISIN: US0345691036
Anebulo Pharmaceuticals, Inc.
ANEB
LISTED
NASDAQ
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
News Preview
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced financial results for the three months ended September 30, 2025, and recent updates.
First Quarter Fiscal Year 2026 and Subse...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US89680M1018
TriSalus Life Sciences, Inc.
TLSI
LISTED
NASDAQ
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
News Preview
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announces financial results for the quarter ended September 30, 2025, and provides an operatio...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US42238H1086
HeartBeam, Inc.
BEAT
LISTED
NASDAQ
HeartBeam Reports Third Quarter 2025 Results
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the third quarter ended September 30, 2025.
Third Quarter & Subsequent 2025 Operational Highlights
The Company continues to make significant pr...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update
News Preview
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced its financial and operating results for the third quarter ended September 30, 2025, and provided a business update.
Th...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: CA75150G1046
Ramm Pharma Corp.
RAMM
LISTED
CSE
RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.
News Preview
TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) is pleased to announce that its previously announced proposed investment transaction (the “Transaction”) with The Global South S.A.S., as outlined in the management information circular (the “Circular”) dated...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Class Action Alert: Levi & Korsinsky Reminds DexCom, Inc. (DXCM) Investors of December 26, 2025 Deadline
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your DexCom, Inc. (NASDAQ: DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=177268&wire=5&utm_campai...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
News Preview
INSIDE INFORMATIONREGULATED INFORMATION...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON PERRIGO...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Did You Suffer Losses in Perrigo Company plc (PRGO)? Contact Levi & Korsinsky About Securities Fraud Claims
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Perrigo Company plc ("Perrigo Company plc") (NYSE: PRGO) concerning possible violations of federal securities laws.Perrigo issued a press release on November 5, 2025, "announc[ing] that it is initiating a stra...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
News Preview
Conference Call Scheduled for today, November 13, 2025, at 5:00pm ET Conference Call Scheduled for today, November 13, 2025, at 5:00pm ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US8723811084
TELA Bio Inc
TELA
LISTED
NASDAQ
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
News Preview
MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) Investors - Contact Levi & Korsinsky Before November 17, 2025
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ: CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area
News Preview
Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US0223071020
Alumis, Inc.
ALMS
LISTED
NASDAQ
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Alumis reports third quarter 2025 financial results and highlights recent progress and anticipated milestones including Phase 3 data in early 1Q 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
News Preview
REGULATED INFORMATION...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US0048901096
Acrivon Therapeutics Inc
ACRV
LISTED
NASDAQ
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancer...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US68622P1093
Oric Pharmaceuticals Inc
ORIC
LISTED
NASDAQ
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
News Preview
Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: CA31447P1009
Fennec Pharmaceuticals Inc
FRX
LISTED
TSX
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that it intends to offer and sell its common shares in an underwritten registered public offering. In addition, Fennec intends to grant the underwriter...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Perrigo Company plc (PRGO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIA...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US68236X1000
Oncology Institute Inc
TOI
LISTED
NASDAQ
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
News Preview
CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US09077B1044
Bioatla Inc
BCAB
LISTED
NASDAQ
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the third quarter ended September 30, 2025 and provided highli...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US4525253062
ImmuCell Corporation
ICCC
LISTED
NASDAQ
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
News Preview
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial result...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
News Preview
Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US0029421007
Aardvark Therapeutics Inc
AARD
LISTED
NASDAQ
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
News Preview
Q32025 Earnings...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
News Preview
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX).
If you currently own shares of Amylyx Pharmaceuticals stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=22470 for...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON Z...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their OptionsIf you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Changes to the Board of Directors
News Preview
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect....
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partne...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US59935P2092
Milestone Scientific Inc
MLSS
LISTED
XASE
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
News Preview
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 14th, 2025, to discuss the company’s financial results...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US09075D1028
BioXyTran, Inc.
BIXT
LISTED
OTC
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
News Preview
BOSTON, MASSACHUSETTS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical-stage biotech company focused on innovative treatments for stroke, Alzheimer’s, and viral infections is pleased to announce the initiation of coverage of its stock by Independent Research, a global equity research firm specializing i...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement
News Preview
13 November 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: FR0012432516
Poxel SA
POXEL
LISTED
EURONEXT
Poxel Reports Revenue for the Third Quarter 2025
News Preview
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today reports its revenue for the quarter ended Septe...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
CSE Bulletin: MOC Eligibility Update
News Preview
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date BIOV...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
San Francisco, California--(Newsfile Corp. - November 13, 2025) - A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly anticipated tre...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans that can power real shifts in health outcome...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US74340E1038
Progyny Inc
PGNY
LISTED
NASDAQ
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
News Preview
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 3:00 p.m. GMT / 10:0...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: CA58469E4085
Medicure Inc.
MPH
LISTED
TSX
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
News Preview
WINNIPEG, MB / ACCESS Newswire / November 13, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarte...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares – October 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Completes Acquisition of Metsera
News Preview
Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
“This strategic milestone represents more than a transaction—it's a deliberate investment in the f...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
News Preview
31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US29415J1060
enVVeno Medical Corporation
NVNO
LISTED
NASDAQ
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
News Preview
IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it has received an unfavorable decision from the U.S. Food & Drug Administration ("FDA") i...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
News Preview
Management to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - plans to host a webinar at 5:00 PM Eastern Time...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
News Preview
LOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - announced that co-founder of eXoZymes, Tyler Korman, PhD, has taken on the role of Chief Scientific Officer, while Amy L...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2025
ISIN: US88066N3035
Tenon Medical, Inc.
TNON
LISTED
NASDAQ
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
News Preview
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~~ SImmetry®+ alpha launch in Q4 2025 advances strategic portfolio ~~ Foundation set for sustained growth through portfolio diversificati...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
